Study ASKB2018001: A randomized, open-labeled, historically controlled, multi-site clinical field study to assess the effectiveness and safety of three different doses of ASKB626 for the management of anemia in cats with IRIS Stage 2 or 3 CKD

Project: Research project

Project Details

Description

Study ASKB2018001: A randomized, open-labeled, historically controlled, multi-site clinical field study to assess the effectiveness and safety of three different doses of ASKB626 for the management of anemia in cats with IRIS Stage 2 or 3 CKD
StatusActive
Effective start/end date2/1/1912/31/20

Funding

  • ALCHERABIO, LLC

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.